Gene Therapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027
The Gene Therapy Market was estimated to be USD 6,659.93 million in 2020 and is poised to grow at a CAGR of 28% by 2027 to reach USD 11,739.75 million.
Gene therapy involves repairing, suppressing, or replacing a dysfunctional gene that causes disease with the aim of restoring normal function. This therapy is used as a promising treatment option for certain genetic disorders, cancer, and viral infections, as well as some genetic disorders such as muscular dystrophy and cystic fibrosis. It also helps drug development to find the right targets and approaches to address the root cause of severe disease. In certain disorders in which a known genetic mutation leads to a deficiency or non-functional protein production, gene therapy may correct the underlying defect and provide a pathway to produce a functional protein. In addition, the risk of gene therapy is low because the new gene introduced is integrated into the patient’s genome and continues to function without interfering with the operation of other genes.
Market Segments
By Gene Type
- Antigen
- Cytokine
- Tumor Suppressor
- Suicide
- Deficiency
- Growth factors
- Receptors
- Others
By Application
- Oncological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Infectious disease
- Other Diseases
Key Players
- Adaptimmune Therapeutics Plc.
- Achieve Life Sciences, Inc.
- Anchiano Therapeutics Ltd.
- Abeona Therapeutics Inc.
- Adverum Biotechnologies, Inc.
- Arbutus Biopharma Corporation
- Applied Genetic Technologies Corporation
Scope of the Report
The research study analyzes the global Gene Therapy industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Gene Therapy Market Report
1. What was the Gene Therapy Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Gene Therapy Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Gene Therapy Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation